Company Announcements

Targeted patient and staff-centric workflows for pharmacy and drug diversion empower healthcare teams to improve medication safety and patient care

WALTHAM, Mass.--(BUSINESS WIRE)--Jun. 9, 2025-- Wolters Kluwer Health today announced extensive updates to its Sentri7^® Drug Diversion and Sentri7^® Pharmacy solutions, reinforcing its commitment to innovation in medication safety, compliance, and patient care. These improvements further equip clinical teams with actionable, data-driven insights to streamline workflows for drug diversion and medication management, ultimately supporting better patient care.

“Our mission is to help healthcare organizations deliver safer, higher-quality care with solutions that optimize the workflows supporting patient care and compliance in today’s demanding healthcare environment,”saidKaren Kobelski, Vice President and General Manager of Clinical Surveillance Compliance & Data Solutions at Wolters Kluwer Health. "With our team's deep expertise in pharmacy, technology, and artificial intelligence, we’re providing customers with critical insights and support to address challenges like medication management, drug diversion prevention, and the opioid crisis.”

Sentri7 Drug Diversion delivers improved workflows
The redesigned Sentri7 Drug Diversion solution introduces a more intuitive interface, enabling teams to detect and manage drug diversion threats with greater precision and efficiency. Healthcare organizations can now act faster and more effectively to mitigate risks, with features like:

• User-friendly dashboard: Consolidates essential risk factors and actionable insights into a single, user-friendly interface to streamline diversion detection follow-up.
• Refined HEAT™ scoring and trend analysis: Quickly identifies high-risk staff across multiple facilities with a Watch List that improves alert monitoring of priority areas of concern.
• Missing medication analysis: Saves time for busy nursing teams by reconciling medication transactions across care areas, enabling timely interventions.

“Sentri7 Drug Diversion has a very mature user interface. It is very straightforward. It is easy to use and train our diversion staff to use. The graphics are very clear to understand. The solution has a HEAT score that it gives when it suspects an employee of diversion. It promotes that information to us and tells us where there is suspicious activity rather than us having to look at the numbers and determine that on our own,” according to a pharmacy manager interviewed by KLAS Research, February 2025.

Sentri7 Pharmacy updates support patient-centered care
The updated Sentri7 Pharmacy solution delivers an efficient, patient-centric workflow to optimize medication therapies, safety and overall cost savings. Key updates include:

• User-friendly interface: Tailored to support rounding workflows for individual patients, in addition to managing targeted medication surveillance across the entire patient population.
• Enhanced documentation tools: Simplified and standardized data entry enhances reporting, enabling pharmacy teams to demonstrate impact with evidence-based metrics.
• Actionable Performance Insights: Provides clear key performance indicators on cost savings, departmental contributions, and patient outcomes.

When asked about Wolters Kluwer’s surveillance solution, one pharmacy analyst noted in a KLAS ResearchApril 2025 interview, “Wolters Kluwer is super engaging and allows for a lot of collaborative work with organizations. The vendor does a good job of meeting organizations where they are at and working toward solutions. Wolters Kluwer has just been great at engaging with end users on how to improve their Sentri7 Pharmacy Surveillance product. I would definitely recommend Sentri7 Pharmacy Surveillance.”

Learn more about the enhanced Sentri7 solutions.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250609112419/en/

Media Contact

André Rebelo
Director, External Communications
Wolters Kluwer Health
+1 (781) 392-2411
andre.rebelo@wolterskluwer.com

Source: Wolters Kluwer Health